Krystal Biotech Inc (KRYS)

R&D Expenses

$14.52M

Quarterly · Period ending: · USD

KRYS logo

KRYS R&D Expenses

Latest reported$14.52M
KRYS Quarterly R&D Expenses ($241.00K → $14.52M)
High-resolution chart · PNG

KRYS r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
14,518,000
15,331,000
16,195,000
13,185,000
14,410,000
14,255,000
13,523,000
13,511,000
15,583,000
10,957,000
11,370,000
10,629,000
12,144,000
12,288,000
10,741,000
11,516,000
10,890,000
8,852,000
9,009,000
6,080,000
6,594,000
6,201,000
5,672,000
5,100,000
3,639,000
3,525,000
4,349,000
3,885,000
4,216,000
3,167,000
2,802,000
1,914,000
1,525,000
1,520,000
1,088,000
1,355,000
446,000
319,000
402,000
241,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.